Sponsor Pipeline

South Egypt Cancer Institute Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
0
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 2/3
2
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07434206 Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of… Thyroid Neoplasms Active, Not Recruiting
NCT07555821 Improving Postoperative Analgesia After Functional Endoscopic Surgery Pain Management After Functional Endoscopic Sinuscopy Not Yet Recruiting
Not specified
NCT07434232 Adding Magnesium Sulfate to Combined Pecto-Intercostal & Serratus Anterior Planes Block… Modified Radical Mastectomy Not Yet Recruiting
NCT07438366 Adding Magnesium Sulphate to Combined Pectointercostal Plane and Erector Spinae Plane… Post-mastectomy Pain Syndrome Not Yet Recruiting
NCT07456761 Effect of Low-dose Pregabalin Retard (82.5 mg) Versus Standard-dose Pregabalin Retard… Laparoscopic Abdominal Surgeries Not Yet Recruiting
Disease Areas
Get alerts when South Egypt Cancer Institute's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free